FDA Adverse Event Reporting System ( FAERS ) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS
United States Food and Drug Administration · Center for Drug Evaluation and Research
Abstract
The US Food and Drug Administration (FDA) performs safety assessments throughout the life cycle of a drug. Postmarketing safety surveillance promotes the identification of adverse events not known at the time of approval. Adverse event reports, also called individual case safety reports (ICSRs), submitted to FDA, are collected and stored in the FDA Adverse Event Reporting System (FAERS). ICSRs stored in FAERS may be reviewed-along with multiple other data sources-to detect potential safety signals and to perform a thorough evaluation to determine if a causal association exists between a drug and an adverse event. Although FAERS is a powerful tool for drug safety surveillance and assessment, understanding the…
Citation impact
- FWCI
- 61.56
- Percentile
- 100%
- References
- 62
Authors
4- ELE. Lake PotterCorresponding
United States Food and Drug Administration, Center for Drug Evaluation and Research
- MRMelissa ReyesCorresponding
United States Food and Drug Administration, Center for Drug Evaluation and Research
- JLJennifer L. Greene-Naples
United States Food and Drug Administration, Center for Drug Evaluation and Research
- GJGerald J. Dal Pan
United States Food and Drug Administration, Center for Drug Evaluation and Research
Topics & keywords
- Adverse Event Reporting System
- Adverse effect
- Postmarketing surveillance
- Medicine
- Event (particle physics)
- Food and drug administration
- Pharmacovigilance
- Computer science